High U.S. Drug Prices, High Obesity Rates, Twisted Economics
August 19, 2023 — The intersection of high U.S. drug prices with its high obesity rates is creating some unusual economics. Kaiser Family Foundation (KFF) and the Peterson Center on Healthcare released an analysis this week that brings this into sharp focus. The analysis tells us that published prices for GLP-1 medicines used for obesity and diabetes are the […]